Answers are grounded in this paper and cite their sources.
Biologic agents are regarded as an effective treatment for a variety of autoimmune diseases. These drugs have an acceptable safety and tolerability profile, although an increasing number of autoimmune conditions have been reported with their use. Additionally, a variety of cutaneous diseases have been associated with their use. Here we report our experience of adverse cutaneous events with the use of biologic agents. An alternative explanation for patients presenting with adverse cutaneous events including drug interactions must be carefully investigated.
No takes yet. Share an insight, caveat, or question.
Sehgal et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: